Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02178280 | Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 30, 2014 | clinicaltrials |
| NCT02169388 | Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy | unknown | Phase 1 | 30 | Shandong UniversityOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00973869 | Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery | unknown | Phase 1 | 30 | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00256334 | Resveratrol for Patients With Colon Cancer | completed | Phase 1 | 11 | University of California, IrvineOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00089076 | MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma | terminated | Phase 1 / Phase 2 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01741597 | Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | May 30, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00183833 | Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183846 | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers | completed | Phase 1 | 22 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183859 | Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan | completed | Phase 1 | 42 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00336141 | Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer | completed | Phase 1 | 10 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT01167816 | Phase I Trial of 5-Azacitidine Plus Gemcitabine in Patients With Advanced Pancreatic Cancer | terminated | Phase 1 | 9 | University of OklahomaOTHER | 1 | May 20, 2014 | clinicaltrials |
| NCT00290719 | Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | terminated | Phase 1 | 6 | University of California, San FranciscoOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01025570 | A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer | terminated | Phase 1 | 3 | University of California, San FranciscoOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00878657 | Intensity-Modulated Radiation Therapy and Gemcitabine in Treating Patients With Locally Advanced Pancreatic Cancer | terminated | Phase 1 | 8 | Rutgers, The State University of New JerseyOTHER | 1 | May 5, 2014 | clinicaltrials |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | unknown | Phase 1 / Phase 2 | 43 | Technical University of MunichOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT00933985 | Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia | terminated | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 2 | May 1, 2014 | clinicaltrials |
| NCT01231919 | MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia | completed | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 2 | Apr 29, 2014 | clinicaltrials |
| NCT00625651 | Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 202 | AmgenINDUSTRY | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00997958 | Study of CellCept for Advanced Pancreatic Cancer | completed | Phase 1 | 12 | Columbia UniversityOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | completed | Phase 1 / Phase 2 | 86 | Chinese PLA General HospitalOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00134069 | Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Apr 16, 2014 | clinicaltrials |
| NCT00203892 | Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma | completed | Phase 1 / Phase 2 | 23 | University of ChicagoOTHER | 1 | Apr 16, 2014 | clinicaltrials |
| NCT01233505 | Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00088933 | Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT00101907 | Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer | terminated | Phase 1 | 41 | AmgenINDUSTRY | 0 | Mar 20, 2014 | clinicaltrials |
| NCT00243854 | Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer | completed | Phase 1 | 8 | Indiana UniversityOTHER | 1 | Mar 18, 2014 | clinicaltrials |
| NCT00890747 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01116635 | Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 24 | University of British ColumbiaOTHER | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01320267 | Single Port Laparoscopic Colectomy(SILS) | withdrawn | Phase 1 / Phase 2 | 0 | University of British ColumbiaOTHER | 0 | Mar 17, 2014 | clinicaltrials |
| NCT01364844 | Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors | completed | Phase 1 | 42 | Daiichi SankyoINDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00101205 | Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma | terminated | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00462553 | Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00499811 | Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction | completed | Phase 1 | 15 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01145456 | Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00113581 | Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer | completed | Phase 1 | 26 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00458731 | Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma | completed | Phase 1 | 57 | National Cancer Institute (NCI)NIH | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01428141 | A Phase I Study of E7050 in Subjects With Solid Tumors | completed | Phase 1 | 18 | Eisai Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00003434 | Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer | terminated | Phase 1 | 8 | Duke UniversityOTHER | 1 | Feb 10, 2014 | clinicaltrials |
| NCT00598247 | A Pilot Study of PPX in Women With Metastatic Colorectal Cancer | completed | Phase 1 | 15 | University of Southern CaliforniaOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT01097512 | AS703569 and Gemcitabine Combination in Advanced Malignancies | completed | Phase 1 | 66 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 2 | Jan 30, 2014 | clinicaltrials |
| NCT01273090 | Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma | completed | Phase 1 | 34 | Children's Oncology GroupNETWORK | 2 | Jan 30, 2014 | clinicaltrials |
| NCT00165594 | A Study of E7070 in Patients With Gastric Cancer | terminated | Phase 1 / Phase 2 | 50 | Eisai Co., Ltd.INDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT02042859 | Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer(EndoHPB) | unknown | Phase 1 | 40 | Ochsner Health SystemOTHER | 0 | Jan 23, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00819754 | A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer(IXO+A) | terminated | Phase 1 / Phase 2 | 23 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00096330 | Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer | completed | Phase 1 | 20 | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Jun 30, 2014source: clinicaltrials